2019
DOI: 10.3390/ijms20092303
|View full text |Cite
|
Sign up to set email alerts
|

Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic db/db Mice

Abstract: This study focuses on the effect of honokiol (HON) on glucose homeostasis, insulin resistance, dyslipidemia, hepatic steatosis, and inflammation in type 2 diabetic db/db mice. Male C57BL/KsJ-db/db mice were fed a normal diet with or without HON (0.02%, w/w) or pioglitazone (PIO, anti-diabetic agent, 0.01%, w/w) for 5 weeks. Blood biomarker, tissue morphology and enzymatic and genetic parameters were determined. PIO significantly decreased food intake, fasting blood glucose, and glycosylated hemoglobin (HbA1c) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 66 publications
0
10
0
Order By: Relevance
“…Also, under the condition of long-term exposure to high blood glucose levels, the HbAlc level significantly increases, which leads to vascular endothelial injury and vascular dysfunction, and is the basis of diabetic vascular complications. Therefore, HbA1c is a simple and reliable marker for testing insulin sensitivity in diabetic patients, and the optimum level of HbA1c is 5.6–7% in patients with T2DM ( Kim and Jung, 2019 ). In diabetic db/db mice, AOS improves hyperglycemia.…”
Section: Discussionmentioning
confidence: 99%
“…Also, under the condition of long-term exposure to high blood glucose levels, the HbAlc level significantly increases, which leads to vascular endothelial injury and vascular dysfunction, and is the basis of diabetic vascular complications. Therefore, HbA1c is a simple and reliable marker for testing insulin sensitivity in diabetic patients, and the optimum level of HbA1c is 5.6–7% in patients with T2DM ( Kim and Jung, 2019 ). In diabetic db/db mice, AOS improves hyperglycemia.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, consistent with previous reports 29 , we found that Pg-treatment further reduced glycogen storage in the liver of db/db mice indicating that glucose incorporation into glycogen was further decreased by the PG-treatment in the diabetic mice. However, it should be noted that such changes in hepatic glucose metabolites could also be induced by hepatic enzyme activities due to increased plasma insulin-counter regulatory hormone levels 30,31 , which were not extensively measured in the present study.…”
Section: Discussionmentioning
confidence: 74%
“…T2DM patients have an abnormal blood lipid profile. Increased serum AST and ALT levels are associated with IR [51,52]. In addition, plasma levels of TG, TC, and LDL were significantly higher than those of normal subjects [53].…”
Section: Discussionmentioning
confidence: 91%